. Author manuscript; available in PMC: 2019 Jun 17.

Published in final edited form as: Biol Blood Marrow Transplant. 2017 Oct 20;24(2):288–293. doi: 10.1016/j.bbmt.2017.10.026

Table 3.

Cost Analysis

	Early	ANC driven	Cost-savings
Cost based on 300 mcg syringe
Filgrastim	$2335	$1167	$1168
Tbo-filgrastim	$2157	$1079	$1078
Cost based on 480 mcg syringe
Filgrastim	$3718	$1859	$1859
Tbo-filgrastim	$3435	$1718	$1717

Cost per patient estimated based on median duration of G-CSF administration (6 days in the early group versus 3 days in the ANC driven group) and average wholesale price per prefilled syringe for filgrastim (Neupogen®, Amgen Inc.) and tbo-filgrastim (Granix®, Teva Pharmaceuticals Inc.)